Protocol H7T-MC-TABL(a) PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet Activation and AggrEgation (PRINCIPLE) - TIMI 44.

Trial Profile

Protocol H7T-MC-TABL(a) PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet Activation and AggrEgation (PRINCIPLE) - TIMI 44.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs Clopidogrel; Prasugrel
  • Indications Coronary artery disease; Coronary disorders; Coronary thrombosis
  • Focus Pharmacodynamics
  • Acronyms PRINCIPLE-TIMI-44
  • Sponsors Eli Lilly
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 28 Jun 2011 Results published in Thrombosis and Haemostasis.
    • 21 Jul 2009 Actual end date (1 Jun 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top